Vivek Borse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vivek Borse has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Rohit Srivastava
Indian Institute of Technology Bombay
11 shared publications- Aditya Narayan Konwar
NanoBioSens Lab, Centre for Nanotechnology, Indian Institute of Technology Guwahati, Guwahati, 781 039, Assam, India
4 shared publications Jasmeen Kaur
Indian Institute of Technology Bombay
3 shared publicationsMosam Preethi
National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India, NH 9, Kukatpally, Industrial Estate
3 shared publications- Rohit Srivastava
Catalysis Research Laboratory, Department of Chemistry, Indian Institute of Technology Ropar, Rupnagar-140001, India
3 shared publications Lavanika Roy
NanoBioSens Lab, Department of Medical Devices, National Institute of Pharmaceutical Education & Research (NIPER) Hyderabad, Hyderabad, 500037, Telangana, India
2 shared publications
Latest Publications
- 7 September 2024
- Published by Springer Nature
- p. 43-68
Introduction to Nanoparticles as a Potential Carrier for Brain Targeting
- 7 September 2024
- Published by Springer Nature
- p. 43-68
Introduction to Nanoparticles as a Potential Carrier for Brain Targeting
- 1 January 2023
- Published by Springer Nature
- p. 51-78
Enzymatic Biosensor Platforms for Diagnosis of Heart Diseases
- 1 January 2023
- Published by Springer Nature
- p. 51-78
Enzymatic Biosensor Platforms for Diagnosis of Heart Diseases
- Open Access
- 3 November 2022
- Published by Elsevier in Biosensors and Bioelectronics: X
- Vol. 12, 100276
Outlook of various diagnostics and nanodiagnostic techniques for COVID-19
- 3 November 2022
- Published by Elsevier in Biosensors and Bioelectronics: X
- Vol. 12, 100276
Open AccessOutlook of various diagnostics and nanodiagnostic techniques for COVID-19
- Open Access
- 8 August 2022
- Published by Elsevier in Biosensors and Bioelectronics: X
- Vol. 11
Role of IL-6 and IL-8 biomarkers for optical and electrochemical based point-of-care detection of oral cancer
- 8 August 2022
- Published by Elsevier in Biosensors and Bioelectronics: X
- Vol. 11
Open AccessRole of IL-6 and IL-8 biomarkers for optical and electrochemical based point-of-care detection of oral cancer
- Open Access
- 1 May 2022
- Published by Elsevier in Biosensors and Bioelectronics: X
- Vol. 10
Strategies for sensitivity enhancement of point-of-care devices
- 1 May 2022
- Published by Elsevier in Biosensors and Bioelectronics: X
- Vol. 10
Open AccessStrategies for sensitivity enhancement of point-of-care devices
- 1 December 2021
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 66, 102934
Lymphatic transport system to circumvent hepatic metabolism for oral delivery of lipid-based nanocarriers
- 1 December 2021
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 66, 102934
Lymphatic transport system to circumvent hepatic metabolism for oral delivery of lipid-based nanocarriers
- 1 April 2021
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 178, 112995
Recent advances in point-of-care diagnostics for oral cancer
- 1 April 2021
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 178, 112995
Recent advances in point-of-care diagnostics for oral cancer
- Open Access
- 9 June 2020
- Published by KEAI Publishing in Sensors International
- Vol. 1, 100015
Current status of point-of-care diagnostic devices in the Indian healthcare system with an update on COVID-19 pandemic
Point-of-care (POC) diagnostic device is an instrument that is used to acquire particular clinical information of patients in clinical as well as resource-limited settings. The conventional clinical diagnostic procedure requires high-end and costly instruments, an expert technician for operation and result interpretation, longer time, etc. that ultimately makes it exhausting and expensive. Although there are a lot of improvements in the medical facilities in the Indian healthcare system, the use of POC diagnostic devices is still in its nascent phase. This review illustrates the status of POC diagnostic devices currently used in clinical setups along with constraints in their use. The devices and technologies that are in the research and development phase across the country that has tremendous potential to elevate the clinical diagnostics scenario along with the diagnosis of ongoing COVID-19 pandemic are emphasized. The implications of using POC diagnostic devices and the future objectives for technological advancements that may eventually uplift the status of healthcare and related sectors in India are also discussed here.
- 9 June 2020
- Published by KEAI Publishing in Sensors International
- Vol. 1, 100015
Open AccessCurrent status of point-of-care diagnostic devices in the Indian healthcare system with an update on COVID-19 pandemic
Point-of-care (POC) diagnostic device is an instrument that is used to acquire particular clinical information of patients in clinical as well as resource-limited settings. The conventional clinical diagnostic procedure requires high-end and costly instruments, an expert technician for operation and result interpretation, longer time, etc. that ultimately makes it exhausting and expensive. Although there are a lot of improvements in the medical facilities in the Indian healthcare system, the use of POC diagnostic devices is still in its nascent phase. This review illustrates the status of POC diagnostic devices currently used in clinical setups along with constraints in their use. The devices and technologies that are in the research and development phase across the country that has tremendous potential to elevate the clinical diagnostics scenario along with the diagnosis of ongoing COVID-19 pandemic are emphasized. The implications of using POC diagnostic devices and the future objectives for technological advancements that may eventually uplift the status of healthcare and related sectors in India are also discussed here.
- 4 May 2020
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 10 (4) , 878-902
Perspectives of characterization and bioconjugation of gold nanoparticles and their application in lateral flow immunosensing
Gold nanoparticles (AuNPs) are an important component in the field of biomedical diagnostics. Because of its unique physicochemical properties, AuNPs have been widely used in biomedical applications such as photothermal cancer therapy, drug delivery, optical imaging, labeling, and biosensing. In this review, we have described synthesis and characterization techniques for AuNPs with recent advancements. Characterization of AuNPs has played an important role in directing its application in various fields and elaborated understanding of its functioning. The characterization techniques used for the analysis of AuNPs utilize its intrinsic properties, such as surface plasmon resonance (SPR) and size-dependent shift in absorption. These properties of AuNPs are furthermore used for the characterization of bioconjugated AuNPs. Surface conjugation of the AuNPs with biomolecules is explored widely for its use in numerous biosensing applications. Biosensor-based diagnostic devices use AuNPs conjugated with a sensing probe for the detection of a specific analyte. AuNPs are also commonly used as a colorimetric sensor in various point-of-care diagnostic techniques. Lateral flow immunosensing (LFIS) technique utilizes AuNPs for the rapid and sensitive detection of various analytes. LFIS is a paper-based detection technique, where the sample containing the analyte flows through the membrane, interacts with immobilized counterparts, and produces results using a detection probe. AuNPs are used as color markers in LFIS, and the presence of an analyte is indicated by the appearance of colored lines on the membrane. The color is a result of the accumulation of AuNP complexes containing the analyte and probe. Effect of characterization parameters of AuNPs on the sensitivity of LFIS, advantages, and disadvantages of using AuNPs for LFIS are discussed concerning the recent reports. Recent applications of AuNPs in LFIS development for the detection of various biomarkers are summarized comprehensively in the table. The review may offer significant insight into the utility of AuNPs for application in the LFIS technique for future development. Schematic representation of the various applications of gold nanoparticles
- 4 May 2020
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 10 (4) , 878-902
Perspectives of characterization and bioconjugation of gold nanoparticles and their application in lateral flow immunosensing
Gold nanoparticles (AuNPs) are an important component in the field of biomedical diagnostics. Because of its unique physicochemical properties, AuNPs have been widely used in biomedical applications such as photothermal cancer therapy, drug delivery, optical imaging, labeling, and biosensing. In this review, we have described synthesis and characterization techniques for AuNPs with recent advancements. Characterization of AuNPs has played an important role in directing its application in various fields and elaborated understanding of its functioning. The characterization techniques used for the analysis of AuNPs utilize its intrinsic properties, such as surface plasmon resonance (SPR) and size-dependent shift in absorption. These properties of AuNPs are furthermore used for the characterization of bioconjugated AuNPs. Surface conjugation of the AuNPs with biomolecules is explored widely for its use in numerous biosensing applications. Biosensor-based diagnostic devices use AuNPs conjugated with a sensing probe for the detection of a specific analyte. AuNPs are also commonly used as a colorimetric sensor in various point-of-care diagnostic techniques. Lateral flow immunosensing (LFIS) technique utilizes AuNPs for the rapid and sensitive detection of various analytes. LFIS is a paper-based detection technique, where the sample containing the analyte flows through the membrane, interacts with immobilized counterparts, and produces results using a detection probe. AuNPs are used as color markers in LFIS, and the presence of an analyte is indicated by the appearance of colored lines on the membrane. The color is a result of the accumulation of AuNP complexes containing the analyte and probe. Effect of characterization parameters of AuNPs on the sensitivity of LFIS, advantages, and disadvantages of using AuNPs for LFIS are discussed concerning the recent reports. Recent applications of AuNPs in LFIS development for the detection of various biomarkers are summarized comprehensively in the table. The review may offer significant insight into the utility of AuNPs for application in the LFIS technique for future development. Schematic representation of the various applications of gold nanoparticles
- 26 January 2020
- Published by Springer Nature
- p. 181-204
Nanobiotechnology Advancements in Lateral Flow Immunodiagnostics
- 26 January 2020
- Published by Springer Nature
- p. 181-204
Nanobiotechnology Advancements in Lateral Flow Immunodiagnostics